Ruud G Nijman1, Henriëtte A Moll, Yvonne Vergouwe, Yolanda B de Rijke, Rianne Oostenbrink. 1. From the *Department of General Paediatrics, Erasmus MC-Sophia Children's Hospital; †Center of Medical Decision Making, Erasmus MC; and ‡Department of Clinical Chemistry, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands.
Abstract
BACKGROUND: C-Reactive protein (CRP) is an important diagnostic marker for serious bacterial infections in febrile children. C-Reactive protein bedside testing could potentially accelerate the diagnostic evaluation and shorten length of stay (LOS). OBJECTIVE: The aim of the study was to study the effect of introducing CRP bedside testing on the LOS of febrile children at the emergency department (ED). DESIGN AND INTERVENTION: A prospective observational study with a preimplementation cohort (2008) with traditional CRP testing and a postimplementation cohort (2009-2011) in which CRP bedside testing was introduced. PATIENTS AND SETTING: All previously healthy children with fever, aged 1 month to 16 years, attending the ED of a university hospital were included; non-ill-appearing children with an upper airway infection were not eligible for CRP bedside testing. ANALYSIS AND MAIN OUTCOME MEASURE: Multivariable linear regression and propensity score analyses were used to determine the effect of CRP bedside testing on the logarithmic transformation length of stay [(log)LOS]. RESULTS: The preimplementation cohort included 609 children of whom 286 (47%) had traditional CRP. The postimplementation cohort included the following 1330 children: 728 (55%) children had bedside CRP and 156 (12%) children had traditional CRP. Bedside CRP significantly lowered the median LOS of children in whom an additional diagnostic CRP test was performed, from 178 minutes (interquartile range, 135-232 minutes) to 148 minutes (interquartile range, 108-200 minutes) (30 minutes, 19% of total LOS). A significant reduction of 15% of the (log)LOS remained after adjusting for other determinants of (log)LOS; propensity score analysis showed a 16% reduction. CONCLUSIONS: C-Reactive protein bedside testing substantially lowered the LOS of children with fever at the ED in whom an additional diagnostic CRP test was performed.
BACKGROUND:C-Reactive protein (CRP) is an important diagnostic marker for serious bacterial infections in febrile children. C-Reactive protein bedside testing could potentially accelerate the diagnostic evaluation and shorten length of stay (LOS). OBJECTIVE: The aim of the study was to study the effect of introducing CRP bedside testing on the LOS of febrile children at the emergency department (ED). DESIGN AND INTERVENTION: A prospective observational study with a preimplementation cohort (2008) with traditional CRP testing and a postimplementation cohort (2009-2011) in which CRP bedside testing was introduced. PATIENTS AND SETTING: All previously healthy children with fever, aged 1 month to 16 years, attending the ED of a university hospital were included; non-ill-appearing children with an upper airway infection were not eligible for CRP bedside testing. ANALYSIS AND MAIN OUTCOME MEASURE: Multivariable linear regression and propensity score analyses were used to determine the effect of CRP bedside testing on the logarithmic transformation length of stay [(log)LOS]. RESULTS: The preimplementation cohort included 609 children of whom 286 (47%) had traditional CRP. The postimplementation cohort included the following 1330 children: 728 (55%) children had bedside CRP and 156 (12%) children had traditional CRP. Bedside CRP significantly lowered the median LOS of children in whom an additional diagnostic CRP test was performed, from 178 minutes (interquartile range, 135-232 minutes) to 148 minutes (interquartile range, 108-200 minutes) (30 minutes, 19% of total LOS). A significant reduction of 15% of the (log)LOS remained after adjusting for other determinants of (log)LOS; propensity score analysis showed a 16% reduction. CONCLUSIONS:C-Reactive protein bedside testing substantially lowered the LOS of children with fever at the ED in whom an additional diagnostic CRP test was performed.
Authors: Charlotte Z Woods-Hill; Danielle W Koontz; Annie Voskertchian; Anping Xie; Judy Shea; Marlene R Miller; James C Fackler; Aaron M Milstone Journal: Pediatr Crit Care Med Date: 2021-09-01 Impact factor: 3.971
Authors: Evelien de Vos-Kerkhof; Ruud G Nijman; Yvonne Vergouwe; Suzanne Polinder; Ewout W Steyerberg; Johan van der Lei; Henriëtte A Moll; Rianne Oostenbrink Journal: PLoS One Date: 2015-05-29 Impact factor: 3.240
Authors: Oliver Van Hecke; Meriel Raymond; Joseph J Lee; Philip Turner; Clare R Goyder; Jan Y Verbakel; Ann Van den Bruel; Gail Hayward Journal: PLoS One Date: 2020-07-06 Impact factor: 3.240
Authors: Dorine Borensztajn; Shunmay Yeung; Nienke N Hagedoorn; Anda Balode; Ulrich von Both; Enitan D Carrol; Juan Emmanuel Dewez; Irini Eleftheriou; Marieke Emonts; Michiel van der Flier; Ronald de Groot; Jethro Adam Herberg; Benno Kohlmaier; Emma Lim; Ian Maconochie; Federico Martinón-Torres; Ruud Nijman; Marko Pokorn; Franc Strle; Maria Tsolia; Gerald Wendelin; Dace Zavadska; Werner Zenz; Michael Levin; Henriette A Moll Journal: BMJ Paediatr Open Date: 2019-06-27
Authors: Dorine M Borensztajn; Nienke N Hagedoorn; Irene Rivero Calle; Ian K Maconochie; Ulrich von Both; Enitan D Carrol; Juan Emmanuel Dewez; Marieke Emonts; Michiel van der Flier; Ronald de Groot; Jethro Herberg; Benno Kohlmaier; Emma Lim; Federico Martinon-Torres; Daan Nieboer; Ruud G Nijman; Marko Pokorn; Franc Strle; Maria Tsolia; Clementien Vermont; Shunmay Yeung; Dace Zavadska; Werner Zenz; Michael Levin; Henriette A Moll Journal: PLoS One Date: 2021-01-07 Impact factor: 3.240
Authors: Charlotte Z Woods-Hill; Anping Xie; John Lin; Heather A Wolfe; Alex S Plattner; Sara Malone; Kathleen Chiotos; Julia E Szymczak Journal: JAC Antimicrob Resist Date: 2022-01-22